GlassScriptPhysician profile
Nithya Lingampalli
NPI 1114567724
$4,529.43
in general payments reported to CMS, 2019-2025
7 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $673 · 2022: $591 · 2023: $1,886 · 2024: $947 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459 · Travel and Lodging: $1,057 · Education: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.57 |
| Travel and Lodging | $1,056.58 |
| Education | $750.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,245.02 | 2021-2025 | Na, Spine & Trauma 3d Navigation, Symphony |
| Globus Medical, INC. | $1,114.92 | 2023-2025 | Rise-L . Rise-L A/L, Xlif |
| Medical Device Business Services, INC. | $999.12 | 2021-2025 | Attune |
| Stryker Corporation | $858.13 | 2021-2025 | Mako, Gamma, Insignia |
| Integra Lifesciences Corporation | $170.65 | 2023 | Tenoglide |
| Medwest Associates | $103.04 | 2022 | |
| Paragon 28, INC. | $38.55 | 2023 | Portfolio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nithya Lingampalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.